CAH · 10-Q · 2026Q3 · Full report

Operating Earnings Growth

CARDINAL HEALTH INC · 2026-11-05 · Importance 29 · Surprise 22

GAAP operating earnings for the three months ended September 30, 2026 increased 13% year over year to $753 million, primarily from higher contributions from branded and specialty pharmaceutical products and the generics program, partly offset by higher acquisition-related costs. Non-GAAP operating earnings rose 17% to $1.0 billion, driven by the same product and generics contributions. GAAP diluted EPS increased 27% to $2.38 and non-GAAP diluted EPS increased 28% to $3.26, with favorable changes in discrete tax items also contributing.

Key facts

• GAAP operating earnings increased 13% year over year to $753 million for the three months ended September 30, 2026. source
• Non-GAAP operating earnings increased 17% year over year to $1.0 billion for the three months ended September 30, 2026. source
• GAAP diluted EPS increased 27% year over year to $2.38 for the three months ended September 30, 2026. source
• Non-GAAP diluted EPS increased 28% year over year to $3.26 for the three months ended September 30, 2026. source
• Branded and specialty pharmaceutical products and the generics program increased GAAP operating earnings; higher acquisition-related costs partially offset the increase. source